Skip to main content
Top
Published in: Intensive Care Medicine 1/2018

01-01-2018 | Understanding the Disease

Non-antiarrhythmic interventions in new onset and paroxysmal sepsis-related atrial fibrillation

Authors: Antoine Vieillard-Baron, John Boyd

Published in: Intensive Care Medicine | Issue 1/2018

Login to get access

Excerpt

Although rarely the primary diagnosis, atrial fibrillation (AF) occurs frequently in critically-ill patients. For instance, in 1341 patients without pre-existing cardiac disease admitted to an intensive care unit, 8.4% exhibited supraventricular arrhythmia, representing AF in 77% of cases [1]. Patients with sepsis appear to be at highest risk; cumulative risk for de novo AF has been reported as 10, 22 and 40% in patients with sepsis, severe sepsis and septic shock, respectively [2]. AF mainly occurs in the first 3 days following admission and is associated with increased ICU-, 30 days-, 90 days-, and 1 year-mortality, even after adjusting for such confounding factors as age, gender, scores of severity, malignancy, and cardiovascular diseases [2]. In 8356 consecutive critically-ill adult patients admitted in medical and surgical ICU, Moss et al. recently reported that de novo AF is associated with increased hospital mortality and length of stay [3]. …
Literature
1.
go back to reference Annane D, Sébille V, Duboc D, Le Heuzey JY, Sadoul N, Bouvier E, Belissant E (2008) Incidence and prognosis of sustained arrhythmias in critically ill patients. Am J Respir Crit Care Med 178:20–25CrossRefPubMed Annane D, Sébille V, Duboc D, Le Heuzey JY, Sadoul N, Bouvier E, Belissant E (2008) Incidence and prognosis of sustained arrhythmias in critically ill patients. Am J Respir Crit Care Med 178:20–25CrossRefPubMed
2.
go back to reference Klein Klouwenberg P, Frencken J, Kuipers S, Ong D, Peelen L, van Vught L, Schultz M, van der Poll T, Bonten M, Cremer O, On behalf of the MARS consortium (2017) Incidence, predictors, and outcomes of new-onset atrial fibrillation in critically ill patients with sepsis. Am J Respir Crit Care Med 195:205–211CrossRefPubMed Klein Klouwenberg P, Frencken J, Kuipers S, Ong D, Peelen L, van Vught L, Schultz M, van der Poll T, Bonten M, Cremer O, On behalf of the MARS consortium (2017) Incidence, predictors, and outcomes of new-onset atrial fibrillation in critically ill patients with sepsis. Am J Respir Crit Care Med 195:205–211CrossRefPubMed
3.
go back to reference Moss T, Forrest Calland J, Enfield K, Gomez-Manjarres D, Ruminski C, DiMarco J, Lake D, Moorman R (2017) New-onset atrial fibrillation in the critically ill. Crit Care Med 45:790–797CrossRefPubMedPubMedCentral Moss T, Forrest Calland J, Enfield K, Gomez-Manjarres D, Ruminski C, DiMarco J, Lake D, Moorman R (2017) New-onset atrial fibrillation in the critically ill. Crit Care Med 45:790–797CrossRefPubMedPubMedCentral
5.
go back to reference Ghassemi M, Richter S, Eche I, Chen T, Danziger J, Celi L (2014) A data-driven approach to optimized medication dosing: a focus on heparin. Intensive Care Med 40:1332–1339CrossRefPubMedPubMedCentral Ghassemi M, Richter S, Eche I, Chen T, Danziger J, Celi L (2014) A data-driven approach to optimized medication dosing: a focus on heparin. Intensive Care Med 40:1332–1339CrossRefPubMedPubMedCentral
6.
go back to reference The Task Force for the management of atrial fibrillation of the European Society of cardiology (ESC) (2016) 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893–2962CrossRef The Task Force for the management of atrial fibrillation of the European Society of cardiology (ESC) (2016) 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893–2962CrossRef
7.
go back to reference Lau D, Nattel S, Kalman J, Sanders P (2017) Modifiable risk factors and atrial fibrillation. Circulation 136:583–596CrossRefPubMed Lau D, Nattel S, Kalman J, Sanders P (2017) Modifiable risk factors and atrial fibrillation. Circulation 136:583–596CrossRefPubMed
8.
go back to reference Krijthe B, Heeringa J, Kors J, Hofman A, Franco O, Witteman J, Stricker B (2013) Serum potassium levels and risk of atrial fibrillation. The Rotterdam study. Int J Cardiol 168:5411–5415CrossRefPubMed Krijthe B, Heeringa J, Kors J, Hofman A, Franco O, Witteman J, Stricker B (2013) Serum potassium levels and risk of atrial fibrillation. The Rotterdam study. Int J Cardiol 168:5411–5415CrossRefPubMed
9.
go back to reference Lu YY, Cheng CC, Chen YC, Lin YK, Chen SA, Chen YJ (2016) Electrolytes disturbances differentially regulate sinoatrial node and pulmonary vein activity: a contribution to hypokalemia-or hyponatremia-induced atrial fibrillation. Heart Rhythm 13:781–788CrossRefPubMed Lu YY, Cheng CC, Chen YC, Lin YK, Chen SA, Chen YJ (2016) Electrolytes disturbances differentially regulate sinoatrial node and pulmonary vein activity: a contribution to hypokalemia-or hyponatremia-induced atrial fibrillation. Heart Rhythm 13:781–788CrossRefPubMed
10.
go back to reference May Khan A, Lubitz S, Sullivan L, Sun J, Levy D, Vasan R, Magnani J, Ellinor P, Benjamin E, Wang T (2013) Low serum magnesium and the development of atrial fibrillation in the community. The Framingham heart study. Circulation 127:33–38CrossRef May Khan A, Lubitz S, Sullivan L, Sun J, Levy D, Vasan R, Magnani J, Ellinor P, Benjamin E, Wang T (2013) Low serum magnesium and the development of atrial fibrillation in the community. The Framingham heart study. Circulation 127:33–38CrossRef
11.
go back to reference Rhodes A, Evans L, Alhazzani W, Levy M, Antonelli M, Ferrer F et al (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43:304–377CrossRefPubMed Rhodes A, Evans L, Alhazzani W, Levy M, Antonelli M, Ferrer F et al (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43:304–377CrossRefPubMed
12.
go back to reference Gordon AC, Perkins GD, Singer M, McAuley DF, Orme RM, Santhakumaran S, Mason AJ, Cross M, Al-Beidh F, Best-Lane J, Brealey D, Nutt CL, McNamee JJ, Reschreiter H, Breen A, Liu KD, Ashby D (2016) Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med 375:1638–1648CrossRefPubMed Gordon AC, Perkins GD, Singer M, McAuley DF, Orme RM, Santhakumaran S, Mason AJ, Cross M, Al-Beidh F, Best-Lane J, Brealey D, Nutt CL, McNamee JJ, Reschreiter H, Breen A, Liu KD, Ashby D (2016) Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med 375:1638–1648CrossRefPubMed
13.
go back to reference Edwards JD, Wilkins RG (1987) Atrial fibrillation precipitated by acute hypovolemia. Br Med J 294:283–284CrossRef Edwards JD, Wilkins RG (1987) Atrial fibrillation precipitated by acute hypovolemia. Br Med J 294:283–284CrossRef
14.
go back to reference Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM (1997) Incidence of and risk factors for atrial fibrillation in older adults. Circulation 96:2455–2461CrossRefPubMed Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM (1997) Incidence of and risk factors for atrial fibrillation in older adults. Circulation 96:2455–2461CrossRefPubMed
15.
go back to reference Schortgen F, Clabault K, Katsahian S, Devaquet J, Mercat A, Deye N, Dellamonica J, Bouadma L, Cook F, Beji O, Brun-Buisson C, Lemaire F, Brochard L (2012) Fever control using external cooling in septic shock. A randomized controlled trial. Am J Respir Crit Care Med 185:1088–1095CrossRefPubMed Schortgen F, Clabault K, Katsahian S, Devaquet J, Mercat A, Deye N, Dellamonica J, Bouadma L, Cook F, Beji O, Brun-Buisson C, Lemaire F, Brochard L (2012) Fever control using external cooling in septic shock. A randomized controlled trial. Am J Respir Crit Care Med 185:1088–1095CrossRefPubMed
16.
go back to reference Gillinov A, Bagiella E, Moskowitz A, Raiten J, Groh M, Bowdish M et al (2016) Rate control versus rhythm control for atrial fibrillation after cardiac surgery. N Engl J Med 374:1911–1921CrossRefPubMedPubMedCentral Gillinov A, Bagiella E, Moskowitz A, Raiten J, Groh M, Bowdish M et al (2016) Rate control versus rhythm control for atrial fibrillation after cardiac surgery. N Engl J Med 374:1911–1921CrossRefPubMedPubMedCentral
Metadata
Title
Non-antiarrhythmic interventions in new onset and paroxysmal sepsis-related atrial fibrillation
Authors
Antoine Vieillard-Baron
John Boyd
Publication date
01-01-2018
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 1/2018
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-017-4986-7

Other articles of this Issue 1/2018

Intensive Care Medicine 1/2018 Go to the issue